Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Low-Field MRI in Stroke Code Patients

NCT: NCT07702968 · RECRUITING

NCT IDNCT07702968
StatusRECRUITING
Start Date2026-04-20
Completion2027-08-01
SponsorLeiden University Medical Center (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the accuracy and feasibility of a portable low-field MRI (Hyperfine) device in patients presenting to the emergency department with suspected acute stroke. All enrolled patients undergo standard clinical imaging (CT, CT angiography, CT perfusion) and additionally receive a low-field MRI scan. Low-field MRI findings are compared to routine CT imaging and final clinical diagnosis. The study aims to determine whether low-field MRI can reliably detect acute ischemic stroke (including lacunar and large vessel occlusion), hemorrhagic stroke, and stroke mimics in the acute setting. Secondary outcomes include feasibility measures such as scan time, completion rate, patient satisfaction, and adverse events.

Frequently Asked Questions

What is Low-Field MRI in Stroke Code Patients?

Low-Field MRI in Stroke Code Patients is a clinical trial registered under NCT07702968. Current status: RECRUITING.

What is the status of NCT07702968?

The current status of NCT07702968 (Low-Field MRI in Stroke Code Patients) is: RECRUITING.

When did Low-Field MRI in Stroke Code Patients start?

Low-Field MRI in Stroke Code Patients started on 2026-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.